Clinical Trials Directory

Trials / Unknown

UnknownNCT04755829

Breath Test to Predict Breast Cancer and Outcome of Mammography

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Menssana Research, Inc. · Industry
Sex
Female
Age
18 Years
Healthy volunteers

Summary

To validate a breath test that predicts risk of breast cancer and an abnormal mammogram.

Detailed description

We will determine the accuracy of volatile organic compounds (VOCs) in the breath as predictors of risk of breast cancer and an abnormal mammogram. Breath samples will be collected using an ultra-clean collection bag and analyzed with gas chromatography surface acoustic wave detection (GC SAW) The study will be performed in two phases: Phase 1: Model-building phase (cross-sectional study): Breath VOCs will be employed to construct multivariate algorithms that distinguish between normal women and those with breast cancer and abnormal screening mammograms. Phase 2: Model-testing phase (cross-sectional study): The predictive accuracy of these algorithms will be tested to predict outcomes in normal women and those with breast cancer and abnormal screening mammograms.

Conditions

Interventions

TypeNameDescription
DEVICEBreathX test for breath VOCsBreath samples are collected into an ultra-clean bag and breath VOCs are analyzed with GC-SAW.

Timeline

Start date
2021-03-01
Primary completion
2023-03-01
Completion
2023-03-01
First posted
2021-02-16
Last updated
2021-02-16

Locations

3 sites across 3 countries: Germany, Netherlands, United Kingdom

Source: ClinicalTrials.gov record NCT04755829. Inclusion in this directory is not an endorsement.